Semaglutide, the popular anti-obesity drug, reduced the rates of COVID-19-related adverse events, including death, in those who had overweight or obesity and established cardiovascular disease without diabetes, according to a new study published in JACC, the flagship journal of the American College of Cardiology.
Hysterectomy Ultimately Needed After 1 in 8 Endometrial Ablations
Hysterectomy rates can be expected to rise slowly in the months and years following endometrial ablation, regardless of ablation device type, a meta-analysis found. Risk
June 24, 2023